Literature DB >> 8753680

Recovery of impaired left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on 123I-BMIPP and 201Tl SPET images.

T Ito1, J Tanouchi, J Kato, T Morioka, M Nishino, K Iwai, H Tanahashi, Y Yamada, M Hori, T Kamada.   

Abstract

A discrepancy between myocardial perfusion defect and wall motion abnormalities is frequently found early after coronary reperfusion in patients with acute myocardial infarction. The purpose of this study was to assess recovery of impaired left ventricular function by reference to the discordance in defect size between myocardial fatty acid uptake and myocardial perfusion using combined single-photon emission tomographic (SPET) imaging early after coronary perfusion therapy. In 37 patients with acute myocardial infarction, iodine-123 15-(p-iodophenyl)-3(R, S)-methylpentadecanoic acid (BMIPP) and thallium-201 SPET scans were performed early after coronary reperfusion. A severity score was determined from the extent of the imaging defect with each tracer. Left ventricular wall motion score (WMS) and ejection fraction (EF) were obtained at admission and at 4 weeks after the onset of infarction. In 32 of the 37 patients, discordance in defect sizes delineated with the two SPET studies was found during the acute stage. The severity score for BMIPP was larger than that for 201Tl during the acute stage (7. 7+/-2.4 vs 4.4+/-2.5, P <0.001). There was a fair correlation between the severity score for BMIPP and WMS (r=0.82, P <0.0001), but a poor correlation between that for 201Tl and WMS. The extent of discordance in severity scores between BMIPP and 201Tl during the acute stage correlated well with the extent of the improvement in WMS (r=0.86, P <0.0001) and that of EF (r=0.85, P <0.0001). We conclude that the discordance in defect size on BMIPP and 201Tl SPET images during the acute stage of infarction is an early predictor of the viability of the myocardium at risk of infarction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753680     DOI: 10.1007/bf01084365

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  23 in total

1.  Metabolism of beta-methyl-heptadecanoic acid in the perfused rat heart and liver.

Authors:  G D Fink; J A Montgomery; F David; M Garneau; E Livni; D Elmaleh; H W Strauss; H Brunengraber
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

2.  Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration.

Authors:  Y Fujibayashi; Y Yonekura; Y Takemura; K Wada; K Matsumoto; N Tamaki; K Yamamoto; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

3.  C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs.

Authors:  H R Schelbert; E Henze; R Keen; H R Schon; H Hansen; C Selin; S C Huang; J R Barrio; M E Phelps
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

4.  Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium.

Authors:  M Schwaiger; H R Schelbert; R Keen; J Vinten-Johansen; H Hansen; C Selin; J Barrio; S C Huang; M E Phelps
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

5.  Use of thallium-201 redistribution scintigraphy in the preoperative differentiation of reversible and nonreversible myocardial asynergy.

Authors:  A Rozanski; D S Berman; R Gray; R Levy; M Raymond; J Maddahi; N Pantaleo; A D Waxman; H J Swan; J Matloff
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

6.  beta-Methyl-15-p-iodophenylpentadecanoic acid metabolism and kinetics in the isolated rat heart.

Authors:  T R DeGrado; J E Holden; C K Ng; D M Raffel; S J Gatley
Journal:  Eur J Nucl Med       Date:  1989

7.  Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model.

Authors:  M Schwaiger; H R Schelbert; D Ellison; H Hansen; L Yeatman; J Vinten-Johansen; C Selin; J Barrio; M E Phelps
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

8.  [Basic studies on I-123-beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor].

Authors:  Y Fujibayashi; Y Yonekura; K Kawai; K Yamamoto; N Tamaki; J Konishi; A Yokoyama; K Torizuka
Journal:  Kaku Igaku       Date:  1988-10

Review 9.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

10.  Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and 123I-beta-methyl-iodo-phenyl pentadecanoic acid.

Authors:  F De Geeter; P R Franken; F F Knapp; A Bossuyt
Journal:  Eur J Nucl Med       Date:  1994-04
View more
  17 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

2.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

3.  Perfusion-BMIPP mismatch: specific finding or artifact?

Authors:  Koichi Morita; Eriko Tsukamoto; Nagara Tamaki
Journal:  Int J Cardiovasc Imaging       Date:  2002-08       Impact factor: 2.357

Review 4.  Future directions of myocardial fatty acid imaging.

Authors:  Christopher J Pastore; John W Babich; James E Udelson
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 5.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 6.  beta-Methyl-p-(123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy.

Authors:  T Nishimura
Journal:  Int J Card Imaging       Date:  1999-02

Review 7.  BMIPP compared with thallium redistribution.

Authors:  J Taki; I Matsunari; K Nakajima; N Tonami
Journal:  Int J Card Imaging       Date:  1999-02

Review 8.  BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction.

Authors:  P R Franken; A S Hambÿe; F W De Geeter
Journal:  Int J Card Imaging       Date:  1999-02

9.  Postrevascularization recovery of fatty acid utilization in ischemic myocardium: a randomized clinical trial of potassium channel opener.

Authors:  Y Kuwabara; S Watanabe; J Nakaya; R Hasegawa; K Matsuno; T Kuroda; Y Mikami; K Fujii; A Miyazaki; T Saito; Y Masuda
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

Review 10.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.